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CORRECTION
In: “MMP9 production by human monocyte-derived macrophages is decreased on polymerized type I
collagen” (Lepidi S, Kenagy RD, Raines EW, Chiu ES, Chait A, Ross R, Clowes AW. J Vasc Surg
2001;34:1111-8).
As the result of an oversight in printing, the version of this article that appears in the December 2001
print issue is an early draft that does not include the authors’ corrections and contains several errors. The 
publisher and editors apologize. The significant corrections are detailed below.
Please note that the complete, correct version of this article was posted online in the “Upcoming Articles”
section of the Journal’s Web site from October 26, 2001, until the December print issue was published on
December 17, 2001. 
The complete, correct version of this article is now posted in the “December 2001” section of the
Journal’s Web site, www.mosby.com/jvs, and is available free of charge to subscribers. 
On page 1113, 11th line from the bottom, “BSA” was incorrectly spelled out as “benzenesulfonic acid,” and
the amount of ethylenediamine tetraacetic acid (EDTA) is incorrectly given as 50 mmol/L. The sentence should
read, “Conditioned medium was diluted 1-to-1 with PBS containing 0.8% Triton, 1% bovine serum albumin, 5
mmol/L ethylenediamine tetraacetic acid, 5 µg/mL aprotinin...”
Also on page 1113, second line from the bottom, the amount of ethylenediamine tetraacetic acid is incorrectly
given as 50 mmol/L. The sentence should read, “...washed twice with PBS containing 0.4% Triton, 5 mmol/L
ethylenediamine tetraacetic acid, and 1% bovine serum albumin.”
On page 1114, the first sentence on the page should be disregarded.
Also on page 1114, in the second-to-last line of the section titled “DNA assay,” the unit of measure is incor-
rectly given as nmol/L. It should read, “... emission wavelengths of 350 to 360 nm and 520 nm, respectively.”
On page 1116, the column heads for the Table are incorrectly placed. The heading over the first column
should be “Collagen”; over the second column, “TNFα”; over the third column, “Experiment 1”; and over the
fourth column, “Experiment 2.”
The complete, correct version of this article is now posted in the “December 2001” section of the
Journal’s Web site, www.mosby.com/jvs, and is available free of charge to subscribers. 
